about
Perspective of Use of Antiviral Peptides against Influenza VirusDesign of shRNAs for RNAi-A lesson from pre-miRNA processing: possible clinical applications.NFIX--one gene, two knockouts, multiple effects.FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiationThe survival of neural precursor cell grafts is influenced by in vitro expansion.Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.Metallothioneins in Prion- and Amyloid-Related Diseases.Label-free and amplification-free miR-124 detection in human cells.Analysis of the prion protein in primates reveals a new polymorphism in codon 226 (Y226F).Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model.Visualization of stable ferritin complexes with palladium, rhodium and iridium nanoparticles detected by their catalytic activity in native polyacrylamide gels.Screening for gene function in chicken embryo using RNAi and electroporation.Haplotype analysis of the fragile X syndrome gene FMR1 in the Czech Republic.Characterization of two nonsense mutations in the human dystrophin gene.Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency[Direct DNA diagnosis of Friedreich's ataxia][Direct detection of mutations in the LDL receptor gene in patients with familial hypercholesterolemia]Prevalent anatase crystalline phase increases the cytotoxicity of biphasic titanium dioxide nanoparticles in mammalian cells
P50
Q26780434-1023A8F0-B966-4913-A272-712EC16CCF80Q33228404-9BE710AF-5142-4AF9-A189-6C4B0E08D320Q33382551-98C2715B-C034-411D-8E4E-C6926DD71A34Q36011320-B4249E3D-24B7-4CE1-83C6-AE7DCB02ECF0Q36268459-FE3CA87F-1B32-4855-8F09-E4CBFA66E87FQ38060257-8747B66B-F385-4C1A-A389-779CF64E7835Q38753411-1B203B0B-D1F6-4D5F-A9D6-CEDAD939F9EDQ38939616-010F22FE-3EB9-4B0A-961E-E372BC1CF73EQ44131875-D1E85D8D-B9BB-4A6C-9AA3-2C008B4FE311Q46205710-8B56D363-234D-49BF-BDC6-E05189780893Q46768187-6D19DA59-22F1-4B0C-A766-2BC72FDFC51CQ48841118-47CC1F5D-4653-4231-8614-DE6F30DC48FAQ51984684-19CC2797-C682-41A1-B709-4BCF454B4E48Q51984919-860FCF7C-16C0-41CE-93B4-7BA7F6A43725Q57562675-71660514-AA9E-4ADE-80E1-A7F7F878DD88Q73269082-35E13CC0-62F4-4027-9A2B-6BDE159AE1BDQ74612814-CEBF380E-BBB6-41A0-8408-79FCD58C32B3Q92389116-D552D0B1-6EBB-4961-B427-8A678F8CF457
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Vladimir Pekarik
@ast
Vladimir Pekarik
@en
Vladimir Pekarik
@es
Vladimir Pekarik
@nl
Vladimir Pekarik
@sl
Vladimír Pekařík
@cs
type
label
Vladimir Pekarik
@ast
Vladimir Pekarik
@en
Vladimir Pekarik
@es
Vladimir Pekarik
@nl
Vladimir Pekarik
@sl
Vladimír Pekařík
@cs
prefLabel
Vladimir Pekarik
@ast
Vladimir Pekarik
@en
Vladimir Pekarik
@es
Vladimir Pekarik
@nl
Vladimir Pekarik
@sl
Vladimír Pekařík
@cs
P214
P1053
I-5816-2014
P106
P21
P214
P31
P3829
P496
0000-0001-6362-9007